100% Original
Niedrigster Preis
Kostenloser Versand

Femogesal 21 Tablets

EGP76

12 Produkte wurden in den letzten 20 Stunden verkauft
Verkauft sich schnell! Über 19 Personen haben in ihrem Warenkorb
29 Personen sehen sich das gerade an
  • Check Mark Estimated Delivery : Same day
  • Check Mark Free Shipping & Returns : On all orders over 200 EGP
  • Visa Card
  • MasterCard
Guaranteed Safe And Secure Checkout

Medication Name: Femogesal 21 Tablets

Active Ingredients:

  • Ethinylestradiol 0.03 mg

  • Gestodene 0.075 mg

Pharmacological Class:
Combined oral contraceptive (estrogen + progestin)

Dosage Form:
Tablets — each pack contains 21 active tablets

Indications:

  • Prevention of pregnancy

  • Regulation of menstrual cycles

  • Reduction of menstrual pain and bleeding

  • Management of acne related to hormonal imbalance (in some cases)

Mechanism of Action:
Femogesal prevents ovulation by suppressing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It also thickens cervical mucus, hindering sperm penetration, and alters the endometrium to prevent implantation.

Dosage and Administration:

  • Take one tablet daily for 21 consecutive days, followed by a 7-day tablet-free interval.

  • Start a new pack after the 7-day break, even if menstruation has not ended.

  • Begin the first tablet on the first day of the menstrual cycle.

Precautions:

  • Contraindicated in women with thromboembolic disorders, severe hypertension, liver disease, or estrogen-dependent tumors.

  • Avoid smoking, especially in women over 35 years old.

  • Not suitable during pregnancy or while breastfeeding.

Possible Side Effects:

  • Nausea or vomiting

  • Breast tenderness

  • Headache or migraine

  • Mood changes

  • Weight changes

  • Breakthrough bleeding or spotting

Storage:
Store below 30°C, in a dry place away from direct sunlight and moisture.

Bewertungen

Es gibt noch keine Bewertungen.

Seien Sie die erste Kundenmeinung "Femogesal 21 Tablets"

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert